Leading UK Pharmacies trust Deltera
Following its 2025 relaunch, Varenicline remains a first-line clinical choice. This PGD manages the 12-week course, with Deltera handling dose increments and monitoring for neuropsychiatric side effects.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
It starts with a 1-week titration before the quit date. Deltera’s system sends automated reminders for the patient to move to the 1mg twice-daily maintenance dose.
Our digital portal allows patients to report changes in mood or behavior. The pharmacist can review these flags in real-time within the Deltera dashboard.
Yes. Deltera manages the supply in stages (e.g., 2 or 4 weeks) while maintaining a single, secure clinical record for the entire 3-month journey.
Yes. Deltera helps you record the 4-week and 12-week quit status, which is vital for both clinical audit and pharmacy service payment claims.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
